Ladenburg Thalmann Financial Services’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $72K | Buy |
3,015
+2,496
| +481% | +$59.6K | ﹤0.01% | 3276 |
|
|
2019
Q3 | $15K | Sell |
519
-610
| -54% | -$17.6K | ﹤0.01% | 4199 |
|
|
2019
Q2 | $37K | Sell |
1,129
-55
| -5% | -$1.8K | ﹤0.01% | 3657 |
|
|
2019
Q1 | $42K | Sell |
1,184
-237
| -17% | -$8.41K | ﹤0.01% | 3526 |
|
|
2018
Q4 | $47K | Buy |
1,421
+655
| +86% | +$21.7K | ﹤0.01% | 3302 |
|
|
2018
Q3 | $39K | Sell |
766
-1,189
| -61% | -$60.5K | ﹤0.01% | 3490 |
|
|
2018
Q2 | $90K | Hold |
1,955
| – | – | ﹤0.01% | 2812 |
|
|
2018
Q1 | $90K | Buy |
1,955
+374
| +24% | +$17.2K | ﹤0.01% | 2812 |
|
|
2017
Q4 | $64K | Sell |
1,581
-275
| -15% | -$11.1K | ﹤0.01% | 3059 |
|
|
2017
Q3 | $75K | Sell |
1,856
-214
| -10% | -$8.65K | ﹤0.01% | 2792 |
|
|
2017
Q2 | $89K | Sell |
2,070
-474
| -19% | -$20.4K | ﹤0.01% | 2592 |
|
|
2017
Q1 | $80K | Sell |
2,544
-321
| -11% | -$10.1K | ﹤0.01% | 2556 |
|
|
2016
Q4 | $72K | Buy |
2,865
+147
| +5% | +$3.69K | ﹤0.01% | 2574 |
|
|
2016
Q3 | $66K | Sell |
2,718
-1,016
| -27% | -$24.7K | ﹤0.01% | 2574 |
|
|
2016
Q2 | $76K | Buy |
3,734
+44
| +1% | +$896 | ﹤0.01% | 2360 |
|
|
2016
Q1 | $56K | Buy |
3,690
+1,482
| +67% | +$22.5K | ﹤0.01% | 2511 |
|
|
2015
Q4 | $30K | Sell |
2,208
-443
| -17% | -$6.02K | ﹤0.01% | 2940 |
|
|
2015
Q3 | $37K | Buy |
2,651
+25
| +1% | +$349 | ﹤0.01% | 2672 |
|
|
2015
Q2 | $45K | Buy |
2,626
+1,415
| +117% | +$24.2K | ﹤0.01% | 2655 |
|
|
2015
Q1 | $15K | Hold |
1,211
| – | – | ﹤0.01% | 3377 |
|
|
2014
Q4 | $10K | Hold |
1,211
| – | – | ﹤0.01% | 3430 |
|
|
2014
Q3 | $11K | Hold |
1,211
| – | – | ﹤0.01% | 3055 |
|
|
2014
Q2 | $13K | Buy |
1,211
+211
| +21% | +$2.27K | ﹤0.01% | 2948 |
|
|
2014
Q1 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 3024 |
|
|
2013
Q4 | $8K | Buy |
+1,000
| New | +$8K | ﹤0.01% | 3060 |
|